期刊文献+

17β-雌二醇睾酮三苯氧胺和氨鲁米特对肺腺癌细胞株A549生长增殖的影响 被引量:1

Effects of 17β-estrogen, testosterone, tamoxifen, and aminoglutethimide on the growth and proliferation of lung adenocarcinoma cell line A549
下载PDF
导出
摘要 目的 检测肺腺癌细胞株A5 49芳香化酶蛋白表达 ,并探讨 17β 雌二醇 (estrogen ,E2 )、睾酮 (testosterone ,T)、雌激素受体拮抗剂三苯氧胺 (tamoxifen ,TAM)和芳香化酶抑制剂氨鲁米特 (DL Aminoglutethimide ,AMIN)对A5 49细胞生长增殖的影响。方法 采用免疫组织化学法检测A5 49细胞株芳香化酶蛋白的表达 ,用流式细胞仪和四唑氮法测定加入E2 、T、TAM和AMIN前后细胞周期和细胞数量的变化。结果 A5 49细胞芳香化酶蛋白表达阳性。芳香化酶抑制剂AMIN和 5× 10 - 7mol L的TAM可抑制A5 49细胞的生长 ,使之阻滞于G0 G1 期 (P <0 0 1和P <0 0 0 1)。当将TAM的浓度提高至 5×10 - 6 mol L ,3d后G2 M期细胞明显减少 ,S期细胞明显增多 (P <0 0 0 1) ;与对照组相比 ,E2 和T均能促进A5 49细胞的生长(P <0 0 1和P <0 0 5 ) ;而单独应用TAM或AMIN则可抑制A5 49细胞的生长 (P <0 0 1和P <0 0 5 ) ,且两者可分别抑制E2和T对A5 49细胞的促生长作用 (P <0 0 1)。结论 E2 和T对A5 49细胞有促生长作用 ,TAM和AMIN能抑制A5 49的生长增殖 ,且可拮抗E2 Objective To determine the aromatase protein expression in A549 cell and to investigate the effects of 17β estrogen (E 2), testosterone (T), estrogen receptor antagonist tamoxifen (TAM), and aromatase inhibitor DL aminoglutethimide (AMIN) on the growth and proliferation of A549 cells. Methods The expression of aromatase protein was determined by immunohistochemical methods. The changes of cell cycle and cell number before and after treatment with E 2, T, TAM, and AMIN were measured by flow cytometry and tetrazolium method (MTT). Results The aromatase protein was positively expressed in A549 cells. The aromatase inhibitor AMIN and 5×10 -7 mol/L TAM could inhibit the growth of A549 cells and block them in G 0/G 1 phase ( P <0.01 or P <0.001). Significantly decreased cells in G 2/M phase but increased cells in S phase were found at 3 d after the concentration of TAM was increased up to 5×10 -6 mol/L ( P <0.001). Compared with the control group, both E 2 and T could promote the growth of A549 cells ( P <0.01 and P <0.05), but TAM or AMIN alone could inhibit the growth of A549 cells ( P <0.01 and P <0.05). Either TAM or AMIN could inhibit the promoting effect of E 2 and T on the growth of A549 cells ( P <0.01) . Conclusion E 2 and T have promoting effect on the growth of A549 cells. TAM and AMIN can inhibit the growth and proliferation of A549 cells and antagonize the effect of E 2 and T.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2004年第2期91-94,共4页 Journal of Third Military Medical University
关键词 肺肿瘤 雌二醇 睾酮 三苯氧胺 芳香化酶 pulmonary carcinoma estradiol testosterone tamoxifen aromatase
  • 相关文献

参考文献3

二级参考文献17

  • 1蔡鹏,刘叙仪,韩复生,王萍.耐顺铂人肺腺癌细胞系A_(549)DDP的建立及耐药机制[J].中国肿瘤临床,1995,22(8):582-587. 被引量:29
  • 2李羲,郭先健,钱桂生,黄桂君.人肺腺癌多药抗药细胞系LC-3/CDDP细胞周期及DNA含量变化[J].河南肿瘤学杂志,1997,10(2):93-93. 被引量:4
  • 3Fairlamb D,Boesen E. Gynaecomastia associated with gonadotrophin-secreting carcinoma of the lung [J]. Postgrad Med J, 1977,53(7):269-271.
  • 4刘国龙,盛信秀.性激素与肿瘤[M].见:性激素与老年疾病.吴赛珠.第1版.北京:中国科学技术出版社,1997:199-211.
  • 5Lu Q,Nakmura J,Savinov A,et al. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers [J]. Endocrinology,1996,137(7):3061-3068.
  • 6Thijssen JH,Daroszewski J,Milewicz A,et al. Local aromatase activity in human breast tissues [J]. J Steroid Biochem Mol Biol,1993,44:577-582.
  • 7Fairlamb D, Boesen E. Gynaecomastiaassociated with gonadotrophin-secreting carcinoma of the lung. Postgrad Med J,1977,53(619)∶269-271.
  • 8Hammer SP. Common Neoplasms Pulmonary Pathology. New York:Aspringer-Verlag,1988.727-785.
  • 9Churg A. Tumors of the Lung, Pathology of the Lung. New York: Thieme MedicalPublishers, Inc,1988.311-423.
  • 10徐兵,周琳,张剑.性激素与肥胖.见:吴赛珠主编.性激素与老年疾病.第1版.北京:中国科学技术出版社,1997.199-203.

共引文献29

同被引文献10

  • 1刁桂香,胡永升,张学斌,袁红民.涎腺粘液表皮样癌中雌激素受体和孕激素受体的表达及意义[J].中华口腔医学杂志,1995,30(1):61-61. 被引量:4
  • 2Jeannon J P, Soames J V, Bell H, et al. Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours [J]. Clin Otolaryngol Allied Sci, 1999, 24( 1 ) : 52 -54.
  • 3Simpson E R, Mahendroo M S, Means G D, et al. Tissue-specific promoters regulate aromatase cytochrome P450 expression [ J ]. Clin Chem, 1993, 39(2) : 317 -324.
  • 4Shozu M, Zhao Y, Bulun S E, et al. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I. 6 [J]. Endocrinology, 1998, 139(4) : 1610-1617.
  • 5Bajetta E, Zilembo N, Buzzoni R, et al. Formestane: effective therapy in postmenopausal women with advanced breast cancer[ J]. Ann Oncol, 1994, (5 Suppl 7) : S15 -S17.
  • 6Beretta K R, Hoeffken K, Kvinnsland S, et al. CGS 16949A, a new aromatase inhibitor in the treatment of breast cancer-a phase Ⅰ study [J]. Ann Oncol, 1990, 1(6):421-426.
  • 7Takayama K, Zeitoun K, Gunby R T, et al. Treatment of severe post-menopausal endometriosis with an aromatase inhibitor[ J]. Fertil Steril, 1998, 69(4) : 709 -713.
  • 8邹雪梅,吴凯,徐竹鸿.芳香化酶P450在子宫内膜癌中的表达及其意义[J].肿瘤研究与临床,2007,19(3):157-158. 被引量:2
  • 9何海琼,王金发.人雄激素芳香化酶基因(CYP19)结构及其表达调控研究进展[J].生物化学与生物物理进展,1998,25(6):492-496. 被引量:4
  • 10李晓霞,吴军正,李巧青,温德升,白忠诚.17β-雌二醇对人涎腺黏液表皮样癌Mc3增殖周期的影响[J].解放军医学杂志,2004,29(5):441-442. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部